TY  - JOUR 
AU  - Valladares Ayerbes, Manuel
PY  - 2012
SN  - 1083-7159
UR  - http://hdl.handle.net/20.500.11940/7770
LA  - eng
TI  - Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study
DO  - 10.1634/theoncologist.2012-0048
T2  - ONCOLOGIST
VL  - 17
ER  -